Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway.

导出 LinkOut

翻译打印收藏纠错

作者： Wei,Gu ^[1] ; Xing,Wang ^[2] ; Huanfen,Zhao ^[3] ; Jianlin,Geng ^[4] ; Xiaolong,Li ^[1] ; Kunjie,Zheng ^[1] ; Yunpeng,Guan ^[5] ; Xiaoyu,Hou ^[5] ; Chao,Wang ^[2] ; Guangyao,Song ^[6]

作者单位： Department of Internal Medicine, Hebei Medical University, Shijiazhuang, China; Department of Endocrinology, Harrison International Peace Hospital, Hengshui, China; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, China. ^[1] Hebei Key Laboratory of Metabolic Diseases, Hebei General Hospital, Shijiazhuang, China. ^[2] Department of Pathology, Hebei General Hospital, Shijiazhuang, China. ^[3] Department of Endocrinology, Harrison International Peace Hospital, Hengshui, China. ^[4] Department of Internal Medicine, Hebei Medical University, Shijiazhuang, China; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, China. ^[5] Department of Internal Medicine, Hebei Medical University, Shijiazhuang, China; Department of Endocrinology, Hebei General Hospital, Shijiazhuang, China. Electronic address: sguangyao2@163.com. ^[6]

关键词 Diabetes Junctional adhesion molecule-like/sirtuin 1 Kidney Lipid deposition Lipotoxicity Resveratrol